Search

Your search keyword '"Dyslipidemias metabolism"' showing total 64 results

Search Constraints

Start Over You searched for: Descriptor "Dyslipidemias metabolism" Remove constraint Descriptor: "Dyslipidemias metabolism" Publisher elsevier science Remove constraint Publisher: elsevier science
64 results on '"Dyslipidemias metabolism"'

Search Results

1. Cyanidin-3-rutinoside from Mori Fructus ameliorates dyslipidemia via modulating gut microbiota and lipid metabolism pathway.

2. Exploring the glycation association with dyslipidaemia: Novel approach for diabetic nephropathy.

3. HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity.

4. Alisol B 23-acetate, a new promoter for cholesterol efflux from dendritic cells, alleviates dyslipidemia and inflammation in advanced atherosclerotic mice.

5. Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling.

6. β-estradiol adjusts intestinal function via ERβ and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia.

7. Oleanolic acid induces a dual agonist action on PPARγ/α and GLUT4 translocation: A pentacyclic triterpene for dyslipidemia and type 2 diabetes.

8. Lipocalin-type prostaglandin D 2 synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease.

9. Memory improvement by modafinil at cost of metabolic hazards? A study to decipher the benefits and risks of modafinil in rats.

10. Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling.

11. Autophagy protects peripheral blood mononuclear cells against inflammation, oxidative and nitrosative stress in diabetic dyslipidemia.

12. Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p'-DDE.

13. Vasoreactivity of isolated aortic rings from dyslipidemic and insulin resistant inducible nitric oxide synthase knockout mice.

14. CD36 signaling in vascular redox stress.

15. Serum metabolomics model and its metabolic characteristics in patients with different syndromes of dyslipidemia based on nuclear magnetic resonance.

16. Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia.

17. Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.

18. Paeoniflorin regulates GALNT2-ANGPTL3-LPL pathway to attenuate dyslipidemia in mice.

19. Dietary protein dilution limits dyslipidemia in obesity through FGF21-driven fatty acid clearance.

20. Inflammation as a Possible Link Between Dyslipidemia and Alzheimer's Disease.

21. Aging affects the response of female rats to a hypercaloric diet.

22. An alternative model for studying age-associated metabolic complications: Senescence-accelerated mouse prone 8.

23. Baked corn (Zea mays L.) and bean (Phaseolus vulgaris L.) snack consumption lowered serum lipids and differentiated liver gene expression in C57BL/6 mice fed a high-fat diet by inhibiting PPARγ and SREBF2.

24. Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity).

25. Simultaneous control of glycemic, blood pressure, and lipid significantly reduce the risk of renal progression in diabetes patients.

26. Cranberry extract attenuates hepatic inflammation in high-fat-fed obese mice.

27. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.

28. Maternal flaxseed oil intake during lactation changes body fat, inflammatory markers and glucose homeostasis in the adult progeny: role of gender dimorphism.

29. Combination effects of wild rice and phytosterols on prevention of atherosclerosis in LDL receptor knockout mice.

30. Auto-inhibitory regulation of angiotensin II functionality in hamster aorta during the early phases of dyslipidemia.

31. Liquid fructose in pregnancy exacerbates fructose-induced dyslipidemia in adult female offspring.

32. Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(shl) mice deficient in apolipoprotein E expression.

33. 4-Phenylbutyric acid regulates CCl4-induced acute hepatic dyslipidemia in a mouse model: A mechanism-based PK/PD study.

34. Epiberberine reduces serum cholesterol in diet-induced dyslipidemia Syrian golden hamsters via network pathways involving cholesterol metabolism.

35. GC-TOF-MS-based serum metabolomic investigations of naked oat bran supplementation in high-fat-diet-induced dyslipidemic rats.

36. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.

37. Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing diet.

38. An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-III.

39. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.

40. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy.

41. Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamsters.

42. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.

43. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue.

44. Metabolic syndrome and urinary stone composition: what factors matter most?

45. Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.

46. Platycodon grandiflorum root attenuates vascular endothelial cell injury by oxidized low-density lipoprotein and prevents high-fat diet-induced dyslipidemia in mice by up-regulating antioxidant proteins.

47. Dyslipidemia in subclinical hypothyroidism in an Indian population.

48. Predictors of insulin resistance in the obese with metabolic syndrome.

49. Improvement of dyslipidemia in OLETF rats by the prostaglandin I(2) analog beraprost sodium.

50. Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.

Catalog

Books, media, physical & digital resources